Please note
This trial is no longer recruiting patients. We hope to add results when they are available.
All cancer types
Closed
Phase 1
This trial is looking at drugs called crizotinib (also known as PF-02341066), PD-0325901 and binimetinib (also known as MEK162).
Recruitment start: 14 November 2014
Recruitment end: 23 October 2018
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Professor Mark Middleton
European Commission
NIHR Clinical Research Network: Cancer
Pfizer
Array Biopharma
University of Oxford
Last reviewed: 21 November 2018
CRUK internal database number: 12517
About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education
What to ask your doctor about clinical trials.
Meet and chat to other cancer people affected by cancer.
Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.
